FX Medicine is at the forefront of ensuring functional and integrative medicine gains the recognition it deserves and ultimately establishes itself as an integral part of standard medical practice. Our podcasts are designed to promote research and evidence based therapeutic practises, acting as a progressive force for change and improvement in patient health and wellbeing.
All content for FX Medicine Podcast Central is the property of FX Medicine and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
FX Medicine is at the forefront of ensuring functional and integrative medicine gains the recognition it deserves and ultimately establishes itself as an integral part of standard medical practice. Our podcasts are designed to promote research and evidence based therapeutic practises, acting as a progressive force for change and improvement in patient health and wellbeing.
Cardiometabolic Rx: Part 2: Interventions and innovations
FX Medicine Podcast Central
1 week ago
Cardiometabolic Rx: Part 2: Interventions and innovations
In part two of our Perspectives podcast, fx Medicine by BioCeuticals ambassadors Lisa Costa-Bir, Dr Michelle Woolhouse, Mick Alexander and Dr Adrian Lopresti, join host Emma Sutherland to explore practical, evidence-aligned treatment strategies for patients with cardiometabolic dysfunction. The discussion covers GLP-1 receptor agonists (GLP-1 RAs) including side effect management and dietary and lifestyle support. They also discuss the evolving landscape of new cardiometabolic medications, and the behavioural, psychological, and social factors that shape long-term cardiometabolic outcomes.
The ambassadors break down current evidence, share their clinic insights from their own practice, and examine how practitioners can better support patients through complementary medicine use, behavioural change, and sustained diet and lifestyle modification. A detailed case study illustrates multidisciplinary reasoning across naturopathy, psychology, pharmacy and general practice, highlighting how small, achievable steps can create meaningful momentum for complex patients.
This episode gives practitioners a comprehensive and compassionate roadmap for supporting sustainable cardiometabolic change in everyday clinical practice.
Covered in this episode:?
(01:06) Welcome back
(01:56) GLP-1 receptor agonists - Lisa
(05:44) GLP-1 receptor agonists - Emma
?(08:16) GLP-1 receptor agonists - Mick
(12:43) GLP-1 receptor agonists - Michelle
(17:51) Complex interplay between statins and GLP-1’s
(22:34) Case study - Lisa's case?
(29:06) Case study - Michelle thoughts
(31:13) Case study - Mick thoughts
(33:12) Case study - Adrian thoughts
?(35:20) Case study - Lisa complementary medicines
(37:37) Case study - Michelle complementary medicines
(40:17) Case study - Mick complementary medicines
(41:24) Innovative treatment for cardiometabolic health
?(46:24) Dealing with difficult cases
(51:07) Favourite resources
?(55:50) Final remarks
Find today's transcript and show notes here:
https://www.bioceuticals.com.au/education/podcasts/cardiometabolic-rx-part-2-interventions-and-innovations
Sign up for our monthly newsletter for the latest exclusive clinical tools, articles, and infographics:
www.bioceuticals.com.au/signup/
DISCLAIMER: The information provided on fx Medicine by BioCeuticals is for educational and informational purposes only. The information provided is not, nor is it intended to be, a substitute for professional advice or care. Please seek the advice of a qualified health care professional in the event something you learn here raises questions or concerns regarding your health.
FX Medicine Podcast Central
FX Medicine is at the forefront of ensuring functional and integrative medicine gains the recognition it deserves and ultimately establishes itself as an integral part of standard medical practice. Our podcasts are designed to promote research and evidence based therapeutic practises, acting as a progressive force for change and improvement in patient health and wellbeing.
